Jazz Pharmaceuticals
S&P 400
$245.80
+2.21%
Delayed · cached 15 min
Frequently asked questions
What sector does Jazz Pharmaceuticals belong to?
Jazz Pharmaceuticals operates in the Health Care sector, specifically the Pharmaceuticals industry, and is listed on the US markets.
What is the current share price of JAZZ?
As of the latest available quote, JAZZ traded at $245.80. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of JAZZ?
Jazz Pharmaceuticals has a price-to-earnings (P/E) ratio of about 16.84. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of JAZZ?
The market capitalisation of Jazz Pharmaceuticals is approximately $14.99B.
Is Jazz Pharmaceuticals profitable?
For its latest reported financial year, Jazz Pharmaceuticals recorded a negative net profit margin of about -8.35% (a net loss for the latest period).
Does JAZZ pay a dividend?
Jazz Pharmaceuticals does not currently show a dividend yield in our data.
What is the return on equity (ROE) of JAZZ?
Jazz Pharmaceuticals has a return on equity (ROE) of about -7.42%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of JAZZ?
Over the past 52 weeks, JAZZ has traded between a low of $123.88 and a high of $266.38.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.